Milan, Italy

Rosanna Dalla Casa

This inventor holds 1 USPTO granted patent. Top assignee: Farmitalia Carlo Erba S.r.l.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rosanna Dalla Casa. Retrieved from https://idiyas.com/inventor/rosanna-dalla-casa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Rosanna Dalla Casa

Introduction

Rosanna Dalla Casa is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable formulations for growth factors. His work has implications for various medical applications, showcasing his innovative spirit and dedication to advancing healthcare.

Latest Patents

Rosanna Dalla Casa holds 1 patent for a stable pharmaceutical composition containing a fibroblast growth factor. This patent describes a stable lyophilized formulation that includes the fibroblast growth factor, a pharmaceutically acceptable bulking agent, and other components. This innovation is crucial for enhancing the stability and efficacy of pharmaceutical products.

Career Highlights

Throughout his career, Rosanna has been associated with Farmitalia Carlo Erba S.r.l., a company known for its commitment to pharmaceutical advancements. His work at the company has allowed him to focus on developing innovative solutions that address critical healthcare needs.

Collaborations

Rosanna has collaborated with esteemed colleagues such as Marco Adami and Luciano Gambini. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their innovations.

Conclusion

Rosanna Dalla Casa's contributions to the pharmaceutical industry exemplify the impact of innovation in healthcare. His patent for a stable formulation of fibroblast growth factor is a testament to his dedication and expertise. Through his work, he continues to pave the way for advancements that can improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…